The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKTIS ONCOLOGY INC | COM | 01021M104 | 30,710,162 | 952,844 | SH | DFND | 0 | 952,844 | 0 | ||
| ALECTOR INC | COM | 014442107 | 7,126,896 | 3,545,719 | SH | DFND | 0 | 3,545,719 | 0 | ||
| EIKON THERAPEUTICS INC | COM | 282564103 | 21,749,991 | 1,666,666 | SH | DFND | 0 | 1,666,666 | 0 | ||
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | 12,804,692 | 1,739,768 | SH | DFND | 0 | 1,739,768 | 0 | ||
| EVAXION BIOTECH A/S | SPONSORED ADS | 29970R303 | 3,763,791 | 1,214,126 | SH | DFND | 0 | 1,214,126 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 88,544,161 | 772,165 | SH | DFND | 0 | 772,165 | 0 | ||
| MODERNA INC | COM | 60770K107 | 161,642,545 | 2,308,190 | SH | DFND | 1 | 0 | 2,308,190 | 0 | |
| NEUPHORIA THERAPEUTICS INC | COM | 64136E102 | 43,818 | 10,027 | SH | DFND | 1 | 0 | 10,027 | 0 | |
| PERSONALIS INC | COM | 71535D106 | 188,202,236 | 14,044,943 | SH | DFND | 1 | 0 | 14,044,943 | 0 | |
| SUTRO BIOPHARMA INC | COM | 869367201 | 9,042,053 | 272,351 | SH | DFND | 1 | 0 | 272,351 | 0 | |
| TUHURA BIOSCIENCES INC | COM | 898920103 | 45,501 | 19,445 | SH | DFND | 1 | 0 | 19,445 | 0 | |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 1,716,015 | 93,414 | SH | DFND | 0 | 93,414 | 0 | ||
| XILIO THERAPEUTICS INC | COM | 98422T209 | 1,015,308 | 105,982 | SH | DFND | 0 | 105,982 | 0 | ||